CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 5,000 target
Drug / intervention
Genome sequencinggenetic
Likely dose
Not stated in record
Key inclusion· 9
  • ✓Willing and able to have study-specific biopsy or resection, or adequate archival material (fresh frozen or FFPE) taken after most recent chemo/radiation, ideally within 16 weeks of consent
  • ✓Must provide blood test or other normal DNA sample for germline genomic analysis
  • ✓ECOG performance status 0 or 1
  • ✓Age 18 years or older
Key exclusion· 4
  • ✕Unable or unwilling to consent to tissue and blood requirements
  • ✕Significant medical condition rendering subject unsuitable for participation or unlikely to be suitable for clinical trial within 12 weeks after POG biopsy
  • ✕Unwilling or unable to provide treatment and outcome follow-up information
  • ✕Unwilling to receive medically actionable findings (germline and/or somatic)

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02155621
NCT02155621N/ARecruitingMonitorUpdated 9mo ago · Completion was 4mo ago
Slow Enrollment
Long Recruiting
Monitor
CompareCT.gov

Personalized OncoGenomics (POG) Program of British Columbia: Connecting Cancer Genomics to Cancer Care

British Columbia Cancer Agency·interventional·Posted Jun 4, 2014·Updated Sep 22, 2025

In Brief

A clinical study evaluating Genome sequencing for Metastatic Cancers and 2 related conditions. Currently recruiting, targeting 5,000 participants across 1 site.

Signals

Enrolling slower than its timeline implies

Detailed Summary

The genomic heterogeneity of cancers implies that to effectively use targeted therapies the investigators will need to assess each individual cancer and match it to a biologically relevant targeted therapy. The investigators will use full genome sequencing to try to identify cancer "drivers" and corresponding drugs that may inhibit these pathways.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMetastatic Cancers, Advanced Cancers, Cancers That Cannot be Treated With Curative Intent
CountriesCanada
CollaboratorsBC Cancer Foundation

Timeline

N/ARecruitingOverdue
201520162017201820192020202120222023202420252026
First PostedJun 4, 2014
Enrollment StartJul 1, 2014
Primary CompletionMar 1, 2026
TodayJul 2, 2026
Enrollment to primary: 11.7 yearsPosted 12.1 years ago

Interventions

Genome sequencinggenetic

Subjects will have their cancers biopsied and blood samples taken; both will undergo genomic sequencing and analysis